# FDA Inspection 865961 - Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site) - December 13, 2013

Source: https://www.keypedia.com/records/fda_inspections/shaanxi-hanjiang-pharmaceutical-group-co-ltd-gaoxin-site/9b848d20-8689-4e55-9199-8304037512f5
Source feed: FDA_Inspections

> FDA inspection 865961 of Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site), December 13, 2013. Classification: Voluntary Action Indicated (VAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 865961
- Company Name: Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site)
- Inspection Date: 2013-12-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1218824 - 2023-09-21](https://www.keypedia.com/records/fda_inspections/shaanxi-hanjiang-pharmaceutical-group-co-ltd-gaoxin-site/1d373f7c-c3d6-48c6-8e4f-a61988516186)
- [FDA Inspection 982472 - 2016-07-15](https://www.keypedia.com/records/fda_inspections/shaanxi-hanjiang-pharmaceutical-group-co-ltd-gaoxin-site/cd38be7b-b076-450f-a100-0b6a6288d3b5)
- FDA Inspection 697592 - 2010-10-14
- FDA Inspection 552585 - 2008-11-21

Company: https://www.keypedia.com/companies/shaanxi-hanjiang-pharmaceutical-group-co-ltd-gaoxin-site/0a902df4-b8bc-4375-bea1-06d35fab1f1e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c